河北医科大学学报

• 论著 • 上一篇    下一篇

rhuEPO辅助治疗对新生儿缺氧缺血性脑病氧化应激损伤及Caspase3、ACT A水平的影响

  

  1. 四川省妇幼保健院新生儿科,四川 成都 610032
  • 出版日期:2017-11-25 发布日期:2017-11-16
  • 作者简介:石境懿(1982-),女,四川成都人,四川省妇幼保健院主治医师,医学学士,从事新生儿常见疾病诊治研究。

Effects of rhuEPO adjuvant therapy on oxidative stress injury and Caspase3 and ACT A levels in neonates with hypoxicischemic encepha lopathy#br#

  1. Department of Neonatology, Sichuan Maternal and Child Health Care Hospital, Chengdu 610032, China
  • Online:2017-11-25 Published:2017-11-16

摘要: [摘要]〓
〖HTH〗目的〖HTSS〗〖KG*2〗探讨重组人促红细胞生成素(recombinant human erythropoietin,rhuEPO)辅助治疗对新生儿缺氧缺血性脑病(hypoxicischemic encephalopath,HIE)氧化应激损伤及半胱氨酸天冬氨酸蛋白酶3(cysteine aspartic protease3,Caspase3)、内源性激活素A(endogenous activin A,ACT A)的影响。
〖HTH〗方法〖HTSS〗〖KG*2〗将130例HIE患者随机分为A组(rhuEPO辅助常规治疗)与B组(常规治疗)各65例,并选择65例同期健康新生儿纳入C组,比较A组与B组在治疗效果、不良反应率差异及3组在治疗当天、治疗1周、治疗4周时超氧化物歧化酶(superoxide dismutase,SOD)、丙二醛(malondialdehyde,MDA)、Caspase3、ACT A、新生儿神经行为测定(neonatal behavioral neurological assessment,NBNA)的差异。
〖HTH〗结果〖HTSS〗〖KG*2〗A组疗效(92.3%)高于B组(70.7%),差异有统计学意义(P<005)。不同时间点C组SOD、MDA、Caspase3、ACT A水平无显著变化,而A、B组SOD水平显著增高,3组在组间、时点间以及组间·时点间交互作用差异均有统计学意义(P<005);A、B组ACT A水平逐渐增高,且B组高于A、C组,3组在组间、时点间以及组间·时点间交互作用差异均有统计学意义(P<005);A、B组Caspase3呈先升高后降低的趋势,3组在组间、时点间以及组间·时点间交互作用差异均有统计学意义(P<005);A、B组MDA水平逐渐下降,3组在组间、时点间以及组间·时点间交互作用差异均有统计学意义(P<005);A、B组NBNA评分逐渐升高,3组在组间、时点间以及组间·时点间交互作用差异均有统计学意义(P<005)。A组不良反应发生率(7.7%)低于B组(30.8%),差异有统计学意义(P<005)。
〖HTH〗结论〖HTSS〗〖KG*2〗Capspase3及ACT A均参与HIE病理生理过程,且通过rhuEPO辅助治疗HIE,有利于降低该病氧化应激损伤及Caspase3、ACT A水平。

关键词: 缺氧缺血, 脑, 重组人促红细胞生成素, 婴儿, 新生

Abstract: [Abstract] Objective〖HTSS〗〓To investigate the effects of rhuEPO on hypoxicischemic encephalopath(HIE) oxidative stress injury and Caspase3, endogenous activin A(ACT A).
〖HTH〗〖WTHZ〗Methods〖HTSS〗〓One hundred and thirty patients with HIE were randomly assigned to group A(rhuEPO adjuvant therapy) and group B(conventional therapy), 65 patients in each group. And 65 cases of healthy newborns were choosen into the group C in order to compare the treatment effect, adverse rate of difference and the differences of superoxide dismutase(SOD), malondialdehyde(MDA), Caspase3, ACT A and neonatal behavioral neurological assessment(NBNA) observed on the day of treatment, 1 week of treatment and 4 weeks of treatment between group A and B.
〖HTH〗〖WTHZ〗Results〖HTSS〗〓Group A efficiency(92.3%) was higher than group B(70.7%), the difference was statistically significant(P<005); The levels of SOD, MDA, Caspase3 and ACT A in group C were not significantly changed in the different time points, while the levels of SOD in group A and group B were significantly higher, there was significant difference in the intergroup, interpoint, and intergroup/hourtime interactions among the three groups(P<005). The levels of ACT A in group A and B were increased gradually, there was significant difference in the intergroup, interpoint, and intergroup/hourtime interactions between the three groups(P<005). The levels of Caspase3 in group A and B were increased first and then decreased, there was significant difference in the intergroup, interpoint, and intergroup/hourtime interactions between the three groups(P<005). The level of MDA in group A and B were decreased gradually, in the intergroup, interpoint, and intergroup/hourtime interactions between the three groups(P<005). The NBNA scores of group A and B were gradually increased, there was significant difference in the intergroup, interpoint, and intergroup/hourtime interactions between the three groups(P<005). The incidence of adverse reactions in A group(7.7%) were lower than the B group(30.8%), the difference was statistically significant.
〖HTH〗〖WTHZ〗Conclusion〖HTSS〗〓Capspase3 and ACT A are involved in the pathophysiological process of HIE, and rhuEPO is used to treat HIE, which is beneficial to reduce the oxidative stress injury and levels of Caspase3 and ACT A.

Key words: hypoxiaischemia, brain, recombinant human erythropoietin, infant, newborn